GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hank who wrote (4991)	7/1/2004 10:47:52 AM
From: Frank_Ching	of 5582

Matrixx Initiatiatives Rated `Neutral' at Roth Capital :MTXX US Page 1/1 Princeton, New Jersey, July 1 (Bloomberg Data) -- Matrixx Initiatives Inc. (MTXX US) was rated new ``neutral'' in new coverage by analyst Mark Taylor at Roth Capital Partners. The price target is $11.00 per share. --Michael O. Donohue in Princeton, New Jersey, (+1)609-279-3756. Story illustration: To graph stock performance for Matrixx Initiatives Inc. : MTXX US Equity GP <GO> . Analyst recommendations history: MTXX US Equity ANR <GO> . For Bloomberg's Analyst Survey : BBSA <GO> . For All Bloomberg Research : BR <GO> .

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next